Zobrazeno 1 - 10
of 153
pro vyhledávání: '"PEGINTERFERON/RIBAVIRIN"'
Publikováno v:
Annals of Hepatology, Vol 11, Iss 6, Pp 827-837 (2012)
Hepatitis C virus (HCV) is an important global health problem with an estimated prevalence of more than 170 million infected individuals worldwide. Currently, the standard antiviral therapy, based on pegylated interferon alpha and ribavirin, can achi
Externí odkaz:
https://doaj.org/article/8d4822c76c444df181dd3606615804fe
Autor:
Shiffman Mitchell L, MD
Publikováno v:
Annals of Hepatology, Vol 3, Iss 1, Pp 5-10 (2004)
The treatment of chronic hepatitis C virus (HCV) has improved greatly over the past decade. Over half of all patients treated with the combination of peginterferon and ribavirin have the opportunity to achieve sustained virologic response. The major
Externí odkaz:
https://doaj.org/article/fe70932d8fca491fa529d3cc2ca6f0ff
Autor:
Cesarec, Laura
Hepatitis C je upalna bolest jetre uzrokovana virusom hepatitisa C otkrivenim 1989. godine. Virus se prenosi parenteralnim putem i predstavlja veliki javnozdravstveni problem, osobito u nerazvijenim zemljama gdje je izražena nedostupnost sterilnog m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::a0c72d5ae3e9c1810af331f5c86ca1bd
https://www.bib.irb.hr/1272871
https://www.bib.irb.hr/1272871
Autor:
Ching-Chang Lee, Wu-Hsien Kuo, Chi-Chang Tsai, Hsin-Wen Lai, Lung-Chih Cheng, Shi-Chi Wen, Jui-Hung Hsu, Pei-Chen Shih
Publikováno v:
Advances in Digestive Medicine. 5:84-92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cf14c436b1d1e79516944da6ed53f7d
https://doi.org/10.1002/aid2.13084
https://doi.org/10.1002/aid2.13084
Autor:
Subrat K. Acharya, Baibaswata Nayak, Sreejith Vasudevan, Bhaskar Thakur, Shalimar, Siddhartha Datta Gupta, Subrat Kumar Panda, Nancy Kalra, Prasenjit Das, A. Kavimandan
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 143, Iss 3, Pp 331-340 (2016)
Indian Journal of Medical Research, Vol 143, Iss 3, Pp 331-340 (2016)
Background & objectives: Standard of care for chronic hepatitis C (CHC) in India is peginterferon and ribavirin (RBV). The response to treatment in real life stetting is unclear. The objectives of this study were to evaluate the demographic profile a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a682bd580bde163f415ba4271f7700dc
http://europepmc.org/articles/PMC4892080
http://europepmc.org/articles/PMC4892080
Publikováno v:
Klimik Dergisi/Klimik Journal. 28:92-94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc69b2376be85f482daa6a6ec8583dfd
https://doi.org/10.5152/kd.2015.18
https://doi.org/10.5152/kd.2015.18
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c998bd12bee36faf7d9e46470560b34
https://pubmed.ncbi.nlm.nih.gov/27200776
https://pubmed.ncbi.nlm.nih.gov/27200776
Publikováno v:
International Journal of Infectious Diseases. 16(1):e67-e71
Summary Background Data are scarce on ocular complications in Egyptian patients with chronic hepatitis C treated with pegylated interferon and ribavirin therapy. The aim of this study was to investigate the development of retinal lesions induced by i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c66d403c903e2632d432c00b56d35883
Publikováno v:
PharmacoEconomics. 30(11):1015-1034
Background and Objective:Background and Objective: In developed countries, injection drug users have the highest prevalence and incidence of hepatitis C virus (HCV) infection. Clinicians and policy makers have several options for reducing morbidity a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547c8943703aed615b9d7e8e6b4e8089
http://PharmacoEconomics.adisonline.com/pt/re/pec/pdfhandler.00019053-201230110-00004.pdf
http://PharmacoEconomics.adisonline.com/pt/re/pec/pdfhandler.00019053-201230110-00004.pdf
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c59ff161bf9f22315b958f147ce482